207 related articles for article (PubMed ID: 8873678)
41. Inhaled carbon monoxide prevents graft-induced intimal hyperplasia in swine.
Ramlawi B; Scott JR; Feng J; Mieno S; Raman KG; Gallo D; Csizmadia E; Yoke Chin B; Bach FH; Otterbein LE; Sellke FW
J Surg Res; 2007 Mar; 138(1):121-7. PubMed ID: 17196991
[TBL] [Abstract][Full Text] [Related]
42. Hepatocyte growth factor prevents intimal hyperplasia in rabbit carotid expanded polytetrafluoroethylene grafting.
Harada M; Takenaka H; Ikenaga S; Zhang H; Zempo N; Esato K; Nagano T; Taiji M; Noguchi H
J Vasc Surg; 2002 Apr; 35(4):786-91. PubMed ID: 11932680
[TBL] [Abstract][Full Text] [Related]
43. Lipoplex gene transfer of inducible nitric oxide synthase inhibits the reactive intimal hyperplasia after expanded polytetrafluoroethylene bypass grafting.
Pfeiffer T; Wallich M; Sandmann W; Schrader J; Gödecke A
J Vasc Surg; 2006 May; 43(5):1021-7. PubMed ID: 16678699
[TBL] [Abstract][Full Text] [Related]
44. Interposition vein cuff and intimal hyperplasia: an experimental study.
Ducasse E; Fleurisse L; Vernier G; Speziale F; Fiorani P; Puppinck P; Creusy C
Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):617-21. PubMed ID: 15121112
[TBL] [Abstract][Full Text] [Related]
45. Antitumor activity of basic fibroblast growth factor-saporin mitotoxin in vitro and in vivo.
Beitz JG; Davol P; Clark JW; Kato J; Medina M; Frackelton AR; Lappi DA; Baird A; Calabresi P
Cancer Res; 1992 Jan; 52(1):227-30. PubMed ID: 1309225
[TBL] [Abstract][Full Text] [Related]
46. Attenuated retinoblastoma gene product and associated E2F/retinoblastoma imbalance in anastomotic intimal hyperplasia.
Sivamurthy N; Stone DH; LoGerfo FW; Quist WC
J Vasc Surg; 2002 Jun; 35(6):1233-41. PubMed ID: 12042736
[TBL] [Abstract][Full Text] [Related]
47. Effect of endoluminal PTFE graft placement on cell proliferation, PDGF secretion, and intimal hyperplasia.
Ombrellaro MP; Stevens SL; Sciarrotta J; Freeman MB; Goldman MH
J Surg Res; 1996 Jun; 63(1):110-4. PubMed ID: 8661182
[TBL] [Abstract][Full Text] [Related]
48. Basic fibroblast growth factor and myointimal hyperplasia after experimental polytetrafluoroethylene arterial grafting.
Sterpetti AV; Cucina A; Randone B; Graziano P; Stipa F; Corvino V; Cavallaro G; Palmieri I; Amato D; Polistena A; Cavallaro A
Eur J Surg; 1999 Aug; 165(8):772-6. PubMed ID: 10494644
[TBL] [Abstract][Full Text] [Related]
49. Identification of multiple genes with altered expression at the distal anastomosis of healing polytetrafluoroethylene grafts.
Cordero JA; Quist WC; Hamdan AD; Phaneuf MD; Contreras MA; LoGerfo FW
J Vasc Surg; 1998 Jul; 28(1):157-66. PubMed ID: 9685142
[TBL] [Abstract][Full Text] [Related]
50. Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model.
Chen C; Lumsden AB; Ofenloch JC; Noe B; Campbell EJ; Stratford PW; Yianni YP; Taylor AS; Hanson SR
Ann Vasc Surg; 1997 Jan; 11(1):74-9. PubMed ID: 9061143
[TBL] [Abstract][Full Text] [Related]
51. Fluid dynamics, wall mechanics, and oxygen transfer in peripheral bypass anastomoses.
Perktold K; Leuprecht A; Prosi M; Berk T; Czerny M; Trubel W; Schima H
Ann Biomed Eng; 2002 Apr; 30(4):447-60. PubMed ID: 12085997
[TBL] [Abstract][Full Text] [Related]
52. Quantitative analysis of anastomotic intimal hyperplasia in paired Dacron and PTFE grafts.
Cantelmo NL; Quist WC; Lo Gerfo FW
J Cardiovasc Surg (Torino); 1989; 30(6):910-5. PubMed ID: 2532216
[TBL] [Abstract][Full Text] [Related]
53. An in vitro endothelialized compliant vascular graft minimizes anastomotic hyperplasia.
Miwa H; Matsuda T; Tani N; Kondo K; Iida F
ASAIO J; 1993; 39(3):M501-5. PubMed ID: 8268587
[TBL] [Abstract][Full Text] [Related]
54. In vivo inhibition of lens regrowth by fibroblast growth factor 2-saporin.
Behar-Cohen FF; David T; D'Hermies F; Pouliquen YM; Buechler Y; Nova MP; Houston LL; Courtois Y
Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2434-48. PubMed ID: 7591633
[TBL] [Abstract][Full Text] [Related]
55. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review.
Haruguchi H; Teraoka S
J Artif Organs; 2003; 6(4):227-35. PubMed ID: 14691664
[TBL] [Abstract][Full Text] [Related]
56. Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts.
Roy-Chaudhury P; Kelly BS; Miller MA; Reaves A; Armstrong J; Nanayakkara N; Heffelfinger SC
Kidney Int; 2001 Jun; 59(6):2325-34. PubMed ID: 11380837
[TBL] [Abstract][Full Text] [Related]
57. Halofuginone, a specific collagen type I inhibitor, reduces anastomotic intimal hyperplasia.
Choi ET; Callow AD; Sehgal NL; Brown DM; Ryan US
Arch Surg; 1995 Mar; 130(3):257-61. PubMed ID: 7887792
[TBL] [Abstract][Full Text] [Related]
58. Effect of basic fibroblast growth factor-saporin (bFGF-SAP) conjugate on bovine choriocapillary endothelial cells.
Kim YH; Kim HS; Yoo JS
Korean J Ophthalmol; 2004 Dec; 18(2):121-31. PubMed ID: 15635825
[TBL] [Abstract][Full Text] [Related]
59. Cryoplasty of the venous anastomosis for prevention of intimal hyperplasia in a validated porcine arteriovenous graft model.
Huijbregts HJ; de Borst GJ; Veldhuis WB; Verhagen HJ; Velema E; Pasterkamp G; Moll FL; Blankestijn PJ; Hoefer IE
Eur J Vasc Endovasc Surg; 2010 May; 39(5):620-6. PubMed ID: 20153668
[TBL] [Abstract][Full Text] [Related]
60. Inhibitory effect of prostaglandin E 1 on intimal thickening caused by poor runoff conditions in the canine autologous vein grafts.
Komori K; Furuyama T; Shoji T; Kume M; Mori E; Yamaoka T; Sugimachi K
J Cardiovasc Pharmacol; 2001 Nov; 38(5):686-92. PubMed ID: 11602815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
